What is Gujarat Kidney And Super Speciality EV-to-FCF?
Gujarat Kidney And Super SpecialityNSE:GKSL -0.30%18 EV-to-FCF is 2,424.63 as of Jul. 09, 2026, which is 54% above its 10-year median of 1,578.14. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 406 Healthcare Providers & Services companies, Gujarat Kidney And Super Speciality ranks worse than 99.75% on this metric.
NSE:GKSL'
s EV-to-FCF Range Over the Past 10 Years
Min: 1383 Med: 1578.14 Max: 2449.46
Current: 2449.46
During the past 4 years, the highest EV-to-FCF of Gujarat Kidney And Super Speciality was 2449.46. The lowest was 1383.00. And the median was 1578.14.
NSE:GKSL's EV-to-FCF is ranked worse than 99.75% of 406
companies
in the Healthcare Providers & Services industry
Industry Median: 17.62
vs NSE:GKSL: 2449.46
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Gujarat Kidney And Super Speciality (NSE:GKSL) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Gujarat Kidney And Super Speciality's PE Ratio (TTM) for today is calculated as:
Gujarat Kidney And Super Speciality's share price for today is ₹128.55.
Gujarat Kidney And Super Speciality's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹2.319.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Gujarat Kidney And Super Speciality EV-to-FCF Related Terms
Gujarat Kidney And Super Speciality EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Kidney And Super Speciality EV-to-FCF Chart
Gujarat Kidney And Super Speciality Annual Data
Trend
Mar23
Mar24
Mar25
Mar26
EV-to-FCF
0.00
0.00
0.00
-4.90
Gujarat Kidney And Super Speciality Quarterly Data
For the Medical Care Facilities subindustry, Gujarat Kidney And Super Speciality's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gujarat Kidney And Super Speciality EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gujarat Kidney And Super Speciality's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Gujarat Kidney And Super Speciality's EV-to-FCF falls into.
Gujarat Kidney And Super Speciality's current Enterprise Value is ₹9,853.7 Mil.
Gujarat Kidney And Super Speciality's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gujarat Kidney And Super Speciality (NSE:GKSL) has a EV-to-FCF of 2,424.63 as of Jul. 09, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Gujarat Kidney And Super Speciality and its competitors. This is 54% above median its historical median of 1,578.14. Over the past decade, Gujarat Kidney And Super Speciality's EV-to-FCF has ranged from 1,383.00 to 2,449.46. According to the industry distribution chart, Gujarat Kidney And Super Speciality ranks #405 out of 406 companies in the Healthcare Providers & Services industry, placing it in the top 99.8%.
Is Gujarat Kidney And Super Speciality's EV-to-FCF too high?
Gujarat Kidney And Super Speciality's current EV-to-FCF of 2,424.63 is 54% above median its 10-year median of 1,578.14. Over the past 10 years, this metric has ranged from a low of 1,383.00 to a high of 2,449.46. The Healthcare Providers & Services industry median EV-to-FCF is 17.62. Gujarat Kidney And Super Speciality's value of 2,424.63 is 13660.7% above this industry median. Based on the distribution chart, Gujarat Kidney And Super Speciality ranks #405 out of 406 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gujarat Kidney And Super Speciality ranks #405 out of 406 companies for EV-to-FCF. This places Gujarat Kidney And Super Speciality in the lower half of its industry. The industry median EV-to-FCF is 17.62. Gujarat Kidney And Super Speciality's value of 2,424.63 is 13660.7% above this benchmark. Historically, Gujarat Kidney And Super Speciality's own EV-to-FCF has ranged from 1,383.00 to 2,449.46 over the past decade. While the company's 10-year median is 1,578.14 vs. the industry median of 17.62, Gujarat Kidney And Super Speciality has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.62, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current EV-to-FCF of 2,424.63 is 13660.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Gujarat Kidney And Super Speciality and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current EV-to-FCF is 2,424.63, which is 54% above median its own 10-year median of 1,578.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current EV-to-FCF of 2,424.63. The current EV-to-FCF is 2,424.63, which is 54% above median its 10-year median of 1,578.14 and 13660.7% above the Healthcare Providers & Services industry median of 17.62. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current EV-to-FCF is 2,424.63 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gujarat Kidney And Super Speciality Business Description
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score
Get the complete analysis for NSE:GKSL
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GKSL has been successfully added to your 